Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Fong

Showing results (21-30 of 198) with videos related to

Pageof 20
Sort By:
Cancer Discovery|May 18, 2021
Conditional Cancer Immunotherapy as a Safer Way to Step on the GasBridget P Keenan, Lawrence Fong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancerTerence W Friedlander, Lawrence Fong
Trends in Cancer|February 27, 2020
Immune Checkpoint Inhibition in Prostate CancerLowell Thorndike Nicholson, Lawrence Fong
Current Oncology Reports|April 14, 2007
Immunotherapy for prostate cancerLawrence Fong, Eric J Small
Immunity|December 20, 2018
Immunity in the Time of MetastasesDavid Y Oh, Lawrence Fong
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigenYafei Hou, Brian Kavanagh, Lawrence Fong
Frontiers in Oncology|August 26, 2022
Editorial: Advancements in immunology and immunotherapy for breast cancerTomoharu Sugie, Roberto Salgado, Lawrence Fong
Trends in Cancer|September 6, 2024
CD4<sup>+</sup> T cells in antitumor immunityElena Montauti, David Y Oh, Lawrence Fong
Nature Reviews. Cancer|March 2, 2012
Unmasking the immune recognition of prostate cancer with CTLA4 blockadeSerena S Kwek, Edward Cha, Lawrence Fong
Nature Cancer|July 26, 2024
γδ T cells as critical anti-tumor immune effectorsMarcel Arias-Badia, Ryan Chang, Lawrence Fong
Pageof 20

Showing results (21-30 of 198) with videos related to

Sort By:
Pageof 20
Cancer Discovery|May 18, 2021
Conditional Cancer Immunotherapy as a Safer Way to Step on the GasBridget P Keenan, Lawrence Fong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancerTerence W Friedlander, Lawrence Fong
Trends in Cancer|February 27, 2020
Immune Checkpoint Inhibition in Prostate CancerLowell Thorndike Nicholson, Lawrence Fong
Current Oncology Reports|April 14, 2007
Immunotherapy for prostate cancerLawrence Fong, Eric J Small
Immunity|December 20, 2018
Immunity in the Time of MetastasesDavid Y Oh, Lawrence Fong
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigenYafei Hou, Brian Kavanagh, Lawrence Fong
Frontiers in Oncology|August 26, 2022
Editorial: Advancements in immunology and immunotherapy for breast cancerTomoharu Sugie, Roberto Salgado, Lawrence Fong
Trends in Cancer|September 6, 2024
CD4<sup>+</sup> T cells in antitumor immunityElena Montauti, David Y Oh, Lawrence Fong
Nature Reviews. Cancer|March 2, 2012
Unmasking the immune recognition of prostate cancer with CTLA4 blockadeSerena S Kwek, Edward Cha, Lawrence Fong
Nature Cancer|July 26, 2024
γδ T cells as critical anti-tumor immune effectorsMarcel Arias-Badia, Ryan Chang, Lawrence Fong
Pageof 20